This pleiotropic effect may involve modulation of the NF-κB/MAPK pathway [45], which drives ALI progression, indicating broader mechanistic actions beyond single-pathway inhibitors such as dexamethasone. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.